Hormone substitution in male hypogonadism (Q33895560)

29 July 2017

1 reference

title

Hormone substitution in male hypogonadism (English)

1 reference

29 July 2017

1 reference

Zitzmann M

1 reference

29 July 2017

Nieschlag E

series ordinal

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Molecular and Cellular Endocrinology

29 July 2017

published in

1 reference

29 July 2017

volume

161

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

73-88

1 reference

The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone), insulin, coagulation and fibrinolytic factors in men with coronary arteriosclerosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Transdermal testosterone substitution therapy for male hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Substitution therapy of hypogonadal men with transdermal testosterone over one year

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pulsatile GnRH-therapy in oligozoospermic men does not improve seminal parameters despite decreased FSH levels

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Strong association between serum levels of leptin and testosterone in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Issues in testosterone replacement in older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Effects of urinary gonadotrophin preparations on human in-vitro immune function.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRH--diagnosis and possible alternative treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Gonadotropin Therapy in Men With Isolated Hypogonadotropic Hypogonadism: The Response to Human Chorionic Gonadotropin Is Predicted by Initial Testicular Size

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Development of anti-human chorionic gonadotropin antibodies in patients with hypogonadotropic hypogonadism. A study of four patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Psychosexual behavior in hypopituitary men: a controlled comparison of gonadotropin and testosterone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Oral testosterone, a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Androgen substitution with testosterone containing nasal drops

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Antibody response against three epitopic domains on human chorionic gonadotropin (hCG) in women and rodents immunized with a beta hCG-based immunocontraceptive vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacokinetic Characteristics, Efficacy, and Safety of Buccal Testosterone in Hypogonadal Males: A Pilot Study1

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Oral Testosterone Load Related to Liver Function in Men with Alcoholic Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacokinetics and pharmacodynamics of testosterone pellets in man

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

An analysis of testosterone implants for androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Testosterone influences spatial cognition in older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Testosterone Substitution Normalizes Elevated Serum Leptin Levels in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Analysis of medical treatment of male infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Time-course effects of human recombinant luteinizing hormone on porcine Leydig cell specific differentiated functions

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Hormone kinetics after intramuscular testosterone cypionate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Antigenicity of human chorionic gonadotrophin preparations in men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Role of FSH in the regulation of spermatogenesis: clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility. Recombinant Human FSH Product Development Group

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Delayed type hypersensitivity to human gonadotropin: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate of testosterone cypionate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Lack of effects of recombinant human GH on spermatogenesis in the adult cynomolgus monkey (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Gonadotropin Therapy Failure Secondary to Human Chorionic Gonadotropin-Induced Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Pharmacology, pharmacokinetics and effects/side-effects of different androgen preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900227-0

7 January 2021

10.1016/S0303-7207(99)00227-0

Identifiers

DOI

1 reference

29 July 2017

1 reference